Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis

Author:

Arabi Yaseen M.12,Dara Saqib I.1,Memish Ziad34,Al Abdulkareem Abdulmajeed5,Tamim Hani M.6,Al‐Shirawi Nehad1,Parrillo Joseph E.7,Dodek Peter8,Lapinsky Stephen9,Feinstein Daniel10,Wood Gordon11,Dial Sandra12,Zanotti Sergio13,Kumar Anand1415,

Affiliation:

1. Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia

2. Department of Respiratory Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia

3. Department of Infectious Diseases, Preventive Medicine Directorate, Ministry of Health, Riyadh, Saudi Arabia

4. College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

5. Department of Hepatobiliary Surgery and Liver Transplantation, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia

6. Department of Epidemiology and Biostatistics, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia

7. Department of Medicine, Cooper Medical School of Rowan University, Camden, NJ

8. St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada

9. Section of Critical Care Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON Canada

10. Moses H. Cone Memorial Hospital, Greensboro, NC

11. Royal Jubilee Hospital/Victoria General Hospital, University of British Columbia, Victoria, BC, Canada

12. Section of Pulmonary Medicine, McGill University, Montreal, QC, Canada

13. Cooper Medical School of Rowan University, Camden, NJ

14. Department of Medical Microbiology and Pharmacology/Therapeutics, Section of Critical Care Medicine and Section of Infectious Diseases, Health Sciences Center and St. Boniface Hospital, University of Manitoba, Winnipeg, MB, Canada

15. Division of Cardiovascular Diseases and Critical Care Medicine, Cooper Medical School of Rowan University, Camden, NJ

Publisher

Wiley

Subject

Hepatology

Reference38 articles.

1. World Health Organization. Global burden of disease.http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_ full.pdf. Accessed August 8 2011.

2. Centers for Disease Control and Prevention. Chronic liver disease or cirrhosis.http://www.cdc.gov/nchs/fastats/liverdis.htm. Accessed August 8 2011.

3. American Liver Foundation. Liver life challenge.http://www.liverfoun dation.org/. Accessed August 8 2011.

4. Centers for Disease Control and Prevention. National hospital discharge survey: 2005 annual summary with detailed diagnosis and procedure data.http://www.cdc.gov/nchs/data/series/sr_13/sr13_165.pdf. Accessed August 8 2011.

5. Outcome predictors of cirrhosis patients admitted to the intensive care unit

Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3